Hi,

first try to build your whole project on plain command line....and see
if there are issues....after that you can try your IDE .. because
IntelliJ has an integrated version and also the support is not really
ready to use...

Kind regards
Karl Heinz Marbaise

On 18.12.23 23:19, Tamás Cservenák wrote:
Well, IDE integrations are completely different stuff... What IDE do you
use?
Can I recommend you to try it out in Terminal instead?

T

On Mon, Dec 18, 2023 at 11:18 PM <mark.yagnatin...@barclays.com.invalid>
wrote:

Thanks!  Just tried in my IDE and it failed, but not sure if that's an
issue with maven or with IDE.
(I have a multi-module project and it tried to download the submodules
instead of using the local source code)

-----Original Message-----
From: Tamás Cservenák <ta...@cservenak.net>
Sent: Monday, December 18, 2023 5:08 PM
To: Maven Users List <users@maven.apache.org>
Cc: subharaj.ma...@gmail.com
Subject: Re: Maven 4.0 release timeline


CAUTION: This email originated from outside our organisation -
ta...@cservenak.net Do not click on links, open attachments, or respond
unless you recognize the sender and can validate the content is safe.
Howdy,

And to reply to the "longer stuff":

Current Maven 4 (on vote, so 3 days if vote passes OK and files land on
Central) is alpha-10.

As with any previous alphas, the _minimal_ requirement is that UT passes,
Maven can build itself, and that to pass Maven IT suite. IT suite is
currently, in this very moment 909 IT tests, but they grow constantly, as
new bugs or new features are added, this link
https://clicktime.symantec.com/15sM1Hx4Zk69FcT4Re31T?h=WCNYF5iZoo32qX5Hxyc8Qrzhc1t-HKpREAcWNL1r7t8=&u=https://github.com/apache/maven-integration-testing/pulse/monthly
shows there were 3 ITs added last, two bugs from alpha-9 and new feature
regarding plugin validation.

As a downer, Maven 4 alpha-11 is FOR SURE expected, already scheduled:

https://clicktime.symantec.com/15sMAxLdUyTL5W6uWkqJh?h=KbxkwIqLoMQYfHx5OCZ4V-Mu7NdrW7MXjqNgyyl25so=&u=https://issues.apache.org/jira/issues/?jql%3Dproject%2520%253D%2520MNG%2520AND%2520fixVersion%2520%253D%25204.0.0-alpha-11

Currently we work on stabilizing resolver and maven (both are alphas!),
and ironing out the new Maven 4 API (thus converting MANY core plugins to
use new API), see here:
https://clicktime.symantec.com/15sM689M2MmjfZGyyCSA5?h=7_-nR2qTzP6RIZLBqH9pHMeQfYQjGw5njIatpLSW6_U=&u=https://github.com/apache/maven/pull/1048

Basically we make sure that the new API delivers _everything_ we need in
core plugins, and even more, as some information trickles from third party
plugins as well. We have to do this "intelligence" work in alpha, where we
can break APIs, as we really need to adjust, adapt and make sure all this
once is set in stone (released as final), will work out for everyone doing
plugin development.

Good news is that Resolver 2.0.0 is pretty much "done":

https://clicktime.symantec.com/15sMFnXuwb8vVSvq4KETK?h=djE-5RAYZwC_J0iiRHe3cw4LXST_S1deoAEfdJrJlfU=&u=https://issues.apache.org/jira/issues/?jql%3Dproject%2520%253D%2520MRESOLVER%2520AND%2520fixVersion%2520%253D%25202.0.0-alpha-6

I am not saying "resolver is done-done", just that we are "over the hill",
as regarding issue numbers over there. Most probably will have some lurking
bugs, like the last one was in Resolver 2 alpha-3 (plagues Maven 4 alpha-9)
about new "jdk" transport. And for sure will have bugs regarding new
transport features, as they are not ironed out fully.

Maven core is completely different, especially due to its API. Hence, the
more (intel) we get the merrier, as we see "core plugins" only.

So please try out, test it and report back.

Thanks
T

On Mon, Dec 18, 2023 at 9:39 PM <mark.yagnatin...@barclays.com.invalid>
wrote:

I'm not the original asker but this kind of answer tends to annoy me.
Yes, there is no "official" release timeline, you're obviously not
going to promise anything, all this is (hopefully?) clear, BUT!
You no doubt have GUESSES.  And your guesses are no doubt better than
that of most uninformed outsiders.
As an outsider, I have no idea what the "status" of maven 4 is, and I
can't even begin to guess how I would find out.
Should I try to catch up on the last few years of traffic on the
developer email lists?
Or perhaps the answer can be divined from the issue tracker?  If so, how?
Is it expected that alpha-10 will be the last alpha, and the next
build will be a beta?
If that is NOT what you expect, then what's the primary hold up?
Are there major features that have yet to be implemented?
Or perhaps the features are mostly done but they're still a bit buggy?
Or perhaps the code quality is pretty solid and you just want to
reserve the right to make backwards incompatible changes, and there's
a policy to not do that after hitting beta?

You get the idea.  As an insider, you probably think to yourself
"there's no telling when we'll be done; it depends on a zillion
unpredictable things".
But as outsiders, we don't even know whether the ETA is a few months
or a few years or a few decades or perhaps just a few weeks.

Sorry if that came off as a bit of a rant :)


-----Original Message-----
From: Karl Heinz Marbaise <khmarba...@gmx.de.INVALID>
Sent: Monday, December 18, 2023 3:18 PM
To: Maven Users List <users@maven.apache.org>; Debraj Manna <
subharaj.ma...@gmail.com>
Subject: Re: Maven 4.0 release timeline


CAUTION: This email originated from outside our organisation -
khmarba...@gmx.de.INVALID Do not click on links, open attachments, or
respond unless you recognize the sender and can validate the content
is safe.
On 18.12.23 06:27, Debraj Manna wrote:
Can someone let me know when Maven 4 is expected to be released?
Where can I view its release timelines?


We are an open source project. We don't have a release timeline.

Maven 4.0.0 will be there when it's there.


If you want to help testing, there is 4.0.0-alpha-9 version available
(at the moment the VOTE for 4.0.0-alpha-10 is running developers list)..



https://clicktime.symantec.com/15t5ejZL3AGSyEFA9Aedx?h=ABJzOQGm-e1Zxyu
IqUZPLWnHHC2LmzcP6V9UINAuTSc=&u=https://clicktime.symantec.com/15sMRSv
UrpW7KLag9S2kZ?h=rxf-w5YKFX3JdAeLcUTmzKYQVnVeiOsR34J0KA2uXC0=&u=https:
//maven.apache.org/download.cgi

https://clicktime.symantec.com/15t5ZuN3aYarZHREbcFVL?h=f4YJm-aS7T_bpjO
AtqB_jneksRphxbi0aG911AdXT1E=&u=https://clicktime.symantec.com/15sMLcj
CQCpWuPkkbsdbw?h=vaqP1yibGHIYESRZVgj1tPm7fyADAiWggnAoeWY0YG4=&u=https:
//maven.apache.org/docs/history.html

https://clicktime.symantec.com/15t5jZkcVmx3PB55gj3na?h=L9e7tA5cT0v2zyk
QUoinwwWFS6c1VuE5zuM7Lmb8XwE=&u=https://clicktime.symantec.com/15sMWH7
mKSBhjHQbgzRuB?h=bqPtExCfUeY4iYwAcxtc3UcDhTouwruYvgogozHywls=&u=https:
//maven.apache.org/mailing-lists.html

Kind regards
Karl Heinz Marbaise
Apache Maven PMC Chairman


---------------------------------------------------------------------
To unsubscribe, e-mail: users-unsubscr...@maven.apache.org
For additional commands, e-mail: users-h...@maven.apache.org

This message is for information purposes only. It is not a
recommendation, advice, offer or solicitation to buy or sell a product
or service, nor an official confirmation of any transaction. It is
directed at persons who are professionals and is intended for the
recipient(s) only. It is not directed at retail customers. This message
is subject to the terms at:

https://clicktime.symantec.com/15sMvS6BcWbfo1YDQnReH?h=qQeTYV3le-OdLOQm017NuvphjZ_WxuzkH69ae-ifmzw=&u=https://www.cib.barclays/disclosures/web-and-email-disclaimer.html
.

For important disclosures, please see:
https://clicktime.symantec.com/15sMqbtu9tv5P4iHsE2Vf?h=RCZ7TALloq1Sdd7
ksGGigWQKNB2yoaC_iXzWu8V_lpQ=&u=https://www.cib.barclays/disclosures/s
ales-and-trading-disclaimer.html regarding marketing commentary from
Barclays Sales and/or Trading desks, who are active market
participants;
https://clicktime.symantec.com/15sMb7K3n3sJ9EEXEYq3o?h=IsbxNzO7vbbhmU4
p-rWTXeYqtzoeDmaxsxetovuVEgo=&u=https://www.cib.barclays/disclosures/b
arclays-global-markets-disclosures.html
regarding our standard terms for Barclays Corporate and Investment
Bank where we trade with you in principal-to-principal wholesale
markets transactions; and in respect to Barclays Research, including
disclosures relating to specific issuers, see:
https://clicktime.symantec.com/15sLvTkn78QYqfd8t5drq?h=Z02PHAXBBgLb55eh0j-U1-p5vFfpDyPg5mVsshTm998=&u=http://publicresearch.barclays.com
.
______________________________________________________________________
____________

If you are incorporated or operating in Australia, read these
important
disclosures:
https://clicktime.symantec.com/15sMfwWLEfYtZB4Sn7ECR?h=FNdrtjdlz3tDT5S
BusDGsBWFKuTJBuG11hzfudQYKgk=&u=https://www.cib.barclays/disclosures/i
mportant-disclosures-asia-pacific.html
.

______________________________________________________________________
____________ For more details about how we use personal information,
see our privacy
notice:
https://clicktime.symantec.com/15sMkmhchHEUy7tNKfdM3?h=93NVNPx0KWrm2EXdoQwv85f_NMhfp4pL_PS3p3GjM88=&u=https://www.cib.barclays/disclosures/personal-information-use.html
.


______________________________________________________________________
____________

This message is for information purposes only. It is not a recommendation,
advice, offer or solicitation to buy or sell a product or service, nor an
official confirmation of any transaction. It is directed at persons who are
professionals and is intended for the recipient(s) only. It is not directed
at retail customers. This message is subject to the terms at:
https://www.cib.barclays/disclosures/web-and-email-disclaimer.html.

For important disclosures, please see:
https://www.cib.barclays/disclosures/sales-and-trading-disclaimer.html
regarding marketing commentary from Barclays Sales and/or Trading desks,
who are active market participants;
https://www.cib.barclays/disclosures/barclays-global-markets-disclosures.html
regarding our standard terms for Barclays Corporate and Investment Bank
where we trade with you in principal-to-principal wholesale markets
transactions; and in respect to Barclays Research, including disclosures
relating to specific issuers, see: http://publicresearch.barclays.com.
__________________________________________________________________________________

If you are incorporated or operating in Australia, read these important
disclosures:
https://www.cib.barclays/disclosures/important-disclosures-asia-pacific.html
.

__________________________________________________________________________________
For more details about how we use personal information, see our privacy
notice: https://www.cib.barclays/disclosures/personal-information-use.html.


__________________________________________________________________________________

---------------------------------------------------------------------
To unsubscribe, e-mail: users-unsubscr...@maven.apache.org
For additional commands, e-mail: users-h...@maven.apache.org



---------------------------------------------------------------------
To unsubscribe, e-mail: users-unsubscr...@maven.apache.org
For additional commands, e-mail: users-h...@maven.apache.org

Reply via email to